Gilead Sciences (GILD) EPS (Basic) Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Basic) Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
169.38% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-52.52% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-45.83% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-185.57% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
4.66% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
53.77% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-7.69% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
8.26% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
53.77% |
| Dec 31, 2025 |
23.94% |
| Sep 30, 2025 |
146.00% |
| Jun 30, 2025 |
21.71% |
| Mar 31, 2025 |
131.74% |
| Dec 31, 2024 |
23.48% |
| Sep 30, 2024 |
-42.86% |
| Jun 30, 2024 |
53.57% |
| Mar 31, 2024 |
-512.35% |
| Dec 31, 2023 |
-12.21% |
| Sep 30, 2023 |
22.38% |
| Jun 30, 2023 |
-7.69% |
| Mar 31, 2023 |
3,950.00% |
| Dec 31, 2022 |
322.58% |
| Sep 30, 2022 |
-30.58% |
| Jun 30, 2022 |
-24.79% |
| Mar 31, 2022 |
-98.55% |
| Dec 31, 2021 |
-75.00% |
| Sep 30, 2021 |
610.34% |
| Jun 30, 2021 |
145.49% |
| Mar 31, 2021 |
12.20% |
| Dec 31, 2020 |
-41.78% |
| Sep 30, 2020 |
131.52% |
| Jun 30, 2020 |
-279.73% |
| Mar 31, 2020 |
-20.65% |
| Dec 31, 2019 |
883.89% |
| Sep 30, 2019 |
-156.79% |
| Jun 30, 2019 |
5.71% |
| Mar 31, 2019 |
31.36% |
| Dec 31, 2018 |
107.31% |
| Sep 30, 2018 |
-22.12% |
| Jun 30, 2018 |
-40.43% |
| Mar 31, 2018 |
-43.00% |
| Dec 31, 2017 |
-225.42% |
| Sep 30, 2017 |
-17.46% |
| Jun 30, 2017 |
-10.31% |
| Mar 31, 2017 |
-19.77% |
| Dec 31, 2016 |
-27.61% |
| Sep 30, 2016 |
-19.75% |
| Jun 30, 2016 |
-14.10% |
| Mar 31, 2016 |
-11.34% |
| Dec 31, 2015 |
40.52% |
| Sep 30, 2015 |
74.44% |
| Jun 30, 2015 |
27.62% |
| Mar 31, 2015 |
100.69% |
| Dec 31, 2014 |
346.15% |
| Sep 30, 2014 |
252.94% |
| Jun 30, 2014 |
368.63% |
| Mar 31, 2014 |
208.51% |
| Dec 31, 2013 |
4.00% |
| Sep 30, 2013 |
13.33% |
| Jun 30, 2013 |
8.51% |
| Mar 31, 2013 |
62.07% |
| Dec 31, 2012 |
13.64% |
| Sep 30, 2012 |
-6.25% |
| Jun 30, 2012 |
-2.08% |
| Mar 31, 2012 |
-29.27% |
| Dec 31, 2011 |
-43.59% |
| Sep 30, 2011 |
-43.53% |
| Jun 30, 2011 |
-40.74% |
| Mar 31, 2011 |
-56.84% |
| Dec 31, 2010 |
-12.36% |
| Sep 30, 2010 |
13.33% |
| Jun 30, 2010 |
28.57% |
| Mar 31, 2010 |
46.15% |
